Discover how DNDi partnered with Privacy Analytics to anonymize clinical trial data, ensuring patient privacy while advancing research on neglected diseases.
Privacy Analytics aids W. L. Gore & Associates Inc in securing regulatory approval for medical device studies using innovative synthetic data to ensure patient privacy.
When the National Association of Chronic Disease Directors (NACDD) planned to publish data dashboards with visualizations showing chronic disease prevalence, it considered potential challenges. To be ...
Tuberculosis (TB) is the 13th leading cause of death globally, even though it is both preventable and curable...
Cosmos, one of the world’s largest community collaborations in the healthcare ecosystem, is used by health systems to facilitate research...
Fresenius Medical Care, the leading provider of products and services treating end-stage kidney disease, has created the world’s largest longitudinal database of clinical dialysis information.
The Drugs for Neglected Diseases initiative (DNDi) has a unique mission: to use an alternative model to develop drugs for neglected diseases...
Zephyr AI is a small, high-growth company with big ambitions. One of their aims is to predict adverse health outcomes...
Information on an individual’s health is among the most sensitive data handled by organizations, and arguably, information on an individual’s...
A major pharmaceutical sponsor had immediate delivery needs for multiple regulators and very short timelines to work within.
Filter by Data Type
Categories